(Q35027593)

5 August 2017

The profile of sabcomeline (SB-202026), a functionally selective M1 receptor partial agonist, in the marmoset (English)

1 reference

5 August 2017

Harries MH

1

1 reference

5 August 2017

Samson NA

series ordinal

2

1 reference

5 August 2017

Cilia J

series ordinal

3

1 reference

5 August 2017

Hunter AJ

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

British Journal of Pharmacology

5 August 2017

1 reference

5 August 2017

124

1 reference

5 August 2017

2

1 reference

5 August 2017

409-415

1 reference

Medicinal chemistry of muscarinic agonists for the treatment of dementia disorders.

5 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

Action of agonists and antagonists at muscarinic receptors present on ileum and atria in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

Effects of central muscarinic-1 receptor stimulation on blood pressure regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

Cholinergic receptor agonists inhibit pirenzepine-induced dysfunction of spontaneous alternation performance in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

On perseveration in aphasics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Central effects of muscarinic agonists and antagonists on hippocampal theta rhythm and blood pressure in the anaesthetised rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Verbal perseveration of dementia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Selective muscarinic receptor agonists and antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Perseveration--the clinical symptoms--in chronic schizophrenia and organic dementia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Cholinergic modulation of memory in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Antagonism of scopolamine-induced memory impairments in rats by the muscarinic agonist RU 35,926 (CI-979).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Amelioration of experimental amnesia (passive avoidance failure) in rodents by the selective M1 agonist AF102B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Differential response to the cholinergic agonist arecoline among different cognitive modalities in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Effects of acute infusion of the muscarinic cholinergic agonist arecoline on verbal memory and visuo-spatial function in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Cholinergic learning deficits in the marmoset produced by scopolamine and ICV hemicholinium.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

The effects of excitotoxic lesions of the basal forebrain on the acquisition, retention and serial reversal of visual discriminations in marmosets.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Comparison of the effects of selective and nonselective muscarinic agonists on cognition and thermoregulation in primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

The utility of salivary amylase as an evaluation of M3 muscarinic agonist activity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Safety and tolerability of CI-979 in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Effect of YM796, a novel muscarinic agonist, on the impairment of passive avoidance response in senescence-accelerated mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Role of ganglionic M-1 and M-2 receptors in the neuronal control of the cardiovascular system of the normotensive rat as determined with pilocarpine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701844

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701844

1 reference

5 August 2017

1 reference

5 August 2017

1 reference